Next generation implicit solvation for atomistic modeling
Next generation implicit solvation for atomistic modeling
批准号:
10544161
负责人:
ALEXEY VLAD ONUFRIEV
金额:
$30.38万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-01-01 至 2025-12-31
关键词:
2019-nCoVACE2AccelerationAddressAffinityAlgorithmsAmino AcidsAreaBindingBinding ProteinsBiological ProcessBiomedical ResearchCellsChemicalsCodeCommunitiesComplexComputer softwareCouplingDNADockingDrug DesignFaceFree EnergyGene ExpressionGoalsHeadHealthHigh Performance ComputingHumanHydration statusIncentivesIndividualIndustry StandardLigandsMethodsModelingModernizationMolecularMolecular ConformationMutationNoisePhysicsProcessPropertyProteinsProtocols documentationReadinessResearchSARS-CoV-2 genomeSamplingScienceSignal PathwaySolventsSpeedStructureTranslatingVirusWaterbasecomputerized toolsconventional therapydesigndrug developmentdrug discoveryelectric dipoleexperimental studyfuture pandemicimprovedin silicoinnovationmodels and simulationmolecular dynamicsmolecular modelingmutantnext generationnovelnovel strategiespandemic diseasepandemic responseprotein foldingreceptorreceptor bindingscreeningsimulationsmall moleculestructural biologytechnology research and developmenttheoriestoolweb-based tool
中文摘要
项目总结。该提案响应PAR-19-253“重点技术研究和
英文摘要
Project Summary. This proposal responds to PAR-19-253 “Focused Technology Research and
Development”. Our main goal is to develop a novel class of implicit solvation models, as accurate, and even
more accurate, than standard explicit solvent models, but much faster. The high accuracy, fast implicit
solvation models will be combined with several innovative strategies to deliver new computational protocols to
improve accuracy and speed of binding free energies prediction, directly relevant to drug design. We will
develop a computational tool for fast screening of existing and potential multiple simultaneous mutations in the
SARS-CoV-2 coronavirus genome for high affinity to human cells, which translates into high infectivity.
Progress in modern bio-molecular sciences, from structural biology to structure-based drug design, is
greatly accelerated by atomic-level modeling and simulations that bridge the gap between theory and
experiment. The so-called implicit solvation models can provide critical advantages in speed and versatility
through representing the effects of solvent – often the most computationally expensive part of such simulations
– in a particularly efficient manner. The resulting speed-up of modeling efforts is critical in many areas such as
protein folding or protein-ligand docking; however, the accuracy of the current fast models does not reach the
standard of the more traditional, but computationally very demanding explicit solvent approach. As a result,
prediction reliability of the practical, fast implicit solvation models remains low. In general, high accuracy is a
prerequisite for quantitative in-silico drug design. Here, the accuracy limitation of the current implicit solvation
framework will be addressed in a novel, systematic way; advantages of the new implicit solvation models will
be demonstrated in the context of improving the accuracy of protein-ligand binding free energy calculations.
We will use a novel approach to systematically add most of the missing explicit solvation effects to the
very basic, but computationally efficient implicit solvation framework of the Poisson and generalized Born (GB)
models, with little computational overhead. The GB model is particularly well suited for molecular dynamics
simulations. We have set high accuracy standards for the new theory: one kT (thermal noise) deviation from
experiment for small molecules hydration, which is better than what most widely used explicit water models,
such as TIP3P, can currently deliver. Based on preliminary results, this goal is within reach. The high accuracy
combined with the expected computational efficiency will usher in the next generation of implicit solvation
models that can make a profound difference in bio-medically relevant atomistic calculations.
Example of an immediate impact: Close to, or better than, “industry standard” accuracy in protein-
ligand binding calculations, but at a significantly reduced computational expense. Example of a long term
impact: Fast, versatile computational tools to analyze binding of viruses to host cells will increase our
preparedness for future pandemics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Next generation implicit solvation for atomistic modeling
-
批准号:10344019
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2022
-
负责人:ALEXEY VLAD ONUFRIEV
-
依托单位:
Explicit ions in implicit solvent: fast and accurate.
-
批准号:9808072
-
项目类别:
-
资助金额:$17.18万
-
财政年份:2019
-
负责人:ALEXEY VLAD ONUFRIEV
-
依托单位:
Analytical Electrostatics: Methods and Biological Applications
-
批准号:8182362
-
项目类别:
-
资助金额:$28.27万
-
财政年份:2006
-
负责人:ALEXEY VLAD ONUFRIEV
-
依托单位:
Analytical Electrostatics: Methods and Biological Applications.
-
批准号:7479091
-
项目类别:
-
资助金额:$21.43万
-
财政年份:2006
-
负责人:ALEXEY VLAD ONUFRIEV
-
依托单位:
Analytical Electrostatics: Methods and Biological Applications
-
批准号:8719123
-
项目类别:
-
资助金额:$28.67万
-
财政年份:2006
-
负责人:ALEXEY VLAD ONUFRIEV
-
依托单位:
Analytical Electrostatics: Methods and Biological Applications.
-
批准号:7906774
-
项目类别:
-
资助金额:$41.42万
-
财政年份:2006
-
负责人:ALEXEY VLAD ONUFRIEV
-
依托单位:
Analytical Electrostatics: Methods and Biological Applications
-
批准号:8322555
-
项目类别:
-
资助金额:$28.2万
-
财政年份:2006
-
负责人:ALEXEY VLAD ONUFRIEV
-
依托单位:
Analytical Electrostatics: Methods and Biological Applications
-
批准号:8520321
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2006
-
负责人:ALEXEY VLAD ONUFRIEV
-
依托单位:
Analytical Electrostatics: Methods and Biological Applications.
-
批准号:7269462
-
项目类别:
-
资助金额:$21.47万
-
财政年份:2006
-
负责人:ALEXEY VLAD ONUFRIEV
-
依托单位:
Analytical Electrostatics: Methods and Biological Applications.
-
批准号:7670426
-
项目类别:
-
资助金额:$21.45万
-
财政年份:2006
-
负责人:ALEXEY VLAD ONUFRIEV
-
依托单位:
Analytical Electrostatics: Methods and Biological Applications.
-
批准号:7919696
-
项目类别:
-
资助金额:$23.48万
-
财政年份:2006
-
负责人:ALEXEY VLAD ONUFRIEV
-
依托单位:
Analytical Electrostatics: Methods and Biological Applications.
-
批准号:7142905
-
项目类别:
-
资助金额:$21.88万
-
财政年份:2006
-
负责人:ALEXEY VLAD ONUFRIEV
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ACE2/AGXT2信号轴在甲基异柳磷诱导斑马鱼神经发育异常过程中的作用机制研究
-
批准号:JCZRLH202600625
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
ACE2 Ser623磷酸化调控MED1促VSMCs功能损伤在移植血管重构中的作用及机制研究
-
批准号:2026JJ50619
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:翁春艳
-
依托单位:
AURKA介导ACE2磷酸化修饰调控内皮细胞衰老在低氧性肺动脉高压中的作用及机制研究
-
批准号:82570085
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:沈慧
-
依托单位:
牛蒡叶倍半萜成分群激活ACE2/Ang1-7/MasR轴调控血管内皮—周细胞互作促缺血性脑卒中血管正常化机制研究
-
批准号:82404910
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2024
-
负责人:郝单丽
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2细胞受体识别及其分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
ACE2通过AMPK/SIRT3调控线粒体代谢改善盐敏感性高血压肾脏纤维化的机制
-
批准号:82460087
-
项目类别:地区科学基金项目
-
资助金额:33.00万元
-
批准年份:2024
-
负责人:赵宇
-
依托单位:
铁皮石斛通过肠道 ACE2 修复 Trp/GPR142 介
导“肠-胰岛 ”轴血糖调控功能的降糖机制研
究
-
批准号:Y24H280055
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:颜美秋
-
依托单位:
人类ACE2变构抑制剂的成药性及其抗广谱冠状病毒感染的机制研究
-
批准号:82330111
-
项目类别:重点项目
-
资助金额:220万元
-
批准年份:2023
-
负责人:刘刚
-
依托单位:
CAFs来源的外泌体负性调控ACE2促进肾透明细胞癌癌栓新辅助靶向耐药的机制研究
-
批准号:82373169
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:顾良友
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2受体识别及细胞入侵机制研究
-
批准号:32300137
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈静
-
依托单位: